Skip to content
Clinical Trials – home
Therapeutic area

Vascular disorders – page 69

  • 837 clinical trials
  • 354 recruiting
  • 378 conditions
  • 28 countries

Conditions in this area

378 conditions with trials, the busiest first

Clinical trials in Vascular disorders

837 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

837 clinical trials

Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Riociguat
  • Sponsor:Bayer AG
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Bayer AG

Cardiovascular disorder+1

Not recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ly3437943 Sodium
  • Sponsor:Eli Lilly & Co.

Giant cell arteritis

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Dexamethasone Phosphate
  • Sponsor:Vaestra Goetalandsregionen

Diabetic retinopathy

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 764524
  • Sponsor:Boehringer Ingelheim International GmbH

Haemoptysis

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Terlipressin
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexmedetomidine
  • Sponsor:CHU Gabriel-Montpied
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Klinikum Der Universitat Munchen AöR
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Afamelanotide
  • Sponsor:Clinuvel Europe Limited
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Iomeprol
  • Sponsor:Hospital General Universitario Dr. Balmis
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Blood-Derived Endothelial Progenitor Cells, Haematopoietic Stem/Progenitor Cells, Activated Dendritic Cells And T Helper Cells
  • Sponsor:Biogencell Ltd.

Substances studied in this area

The therapies tested most often in Vascular disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.